MEP6308A - Granulirani preparati gaboksadola - Google Patents

Granulirani preparati gaboksadola

Info

Publication number
MEP6308A
MEP6308A MEP-63/08A MEP6308A MEP6308A ME P6308 A MEP6308 A ME P6308A ME P6308 A MEP6308 A ME P6308A ME P6308 A MEP6308 A ME P6308A
Authority
ME
Montenegro
Prior art keywords
gaboxadol
granular preparations
granular
preparations
Prior art date
Application number
MEP-63/08A
Other languages
English (en)
Inventor
Michiel Onne Elema
Lene Andresen
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MEP6308A publication Critical patent/MEP6308A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MEP-63/08A 2001-05-21 2002-05-17 Granulirani preparati gaboksadola MEP6308A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100817 2001-05-21
PCT/DK2002/000332 WO2002094225A1 (en) 2001-05-21 2002-05-17 Granular preparations of gaboxadol

Publications (1)

Publication Number Publication Date
MEP6308A true MEP6308A (xx) 2010-02-10

Family

ID=8160520

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-63/08A MEP6308A (xx) 2001-05-21 2002-05-17 Granulirani preparati gaboksadola

Country Status (26)

Country Link
US (1) US20040157876A1 (sh)
EP (1) EP1389091A1 (sh)
JP (1) JP2004530695A (sh)
KR (1) KR20030097890A (sh)
CN (1) CN1511026A (sh)
AR (1) AR033896A1 (sh)
AU (1) AU2002338855B2 (sh)
BG (1) BG108441A (sh)
BR (1) BR0209834A (sh)
CA (1) CA2447603A1 (sh)
CZ (1) CZ20033269A3 (sh)
EA (2) EA200700703A1 (sh)
HR (1) HRP20030950A2 (sh)
HU (1) HUP0400051A2 (sh)
IL (1) IL158733A0 (sh)
IS (1) IS7020A (sh)
ME (1) MEP6308A (sh)
MX (1) MXPA03010596A (sh)
NO (1) NO20035146D0 (sh)
NZ (1) NZ547636A (sh)
PL (1) PL366541A1 (sh)
SK (1) SK15542003A3 (sh)
UA (1) UA80092C2 (sh)
WO (1) WO2002094225A1 (sh)
YU (1) YU92103A (sh)
ZA (1) ZA200308594B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510266A (ja) * 1999-09-28 2003-03-18 ハー・ルンドベック・アクチエゼルスカベット 溶融顆粒化された調合物及びこの調合物から製造された、放出が調節された投薬形
PL1641456T3 (pl) 2003-06-25 2010-08-31 H Lundbeck As Gaboksadol do leczenia depresji i innych zaburzeń afektywnych
TW200528098A (en) * 2003-12-18 2005-09-01 Lundbeck & Co As H Treatment of insomnia in human patients
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
US8022084B2 (en) 2005-01-28 2011-09-20 H. Lundbeck A/S Polymorphic forms of a GABAA agonist
WO2006118897A1 (en) * 2005-04-29 2006-11-09 H.Lundbeck A/S Acid and base salt forms of gaboxadol
US20090298850A1 (en) * 2008-05-30 2009-12-03 Psychogenics, Inc. Treatment for Neurological and Mental Disorders
EP2334299A1 (en) * 2008-09-01 2011-06-22 H. Lundbeck A/S Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat
CA2859174C (en) 2011-12-12 2019-03-05 Orbis Biosciences, Inc. Sustained release particle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
JP2003510266A (ja) * 1999-09-28 2003-03-18 ハー・ルンドベック・アクチエゼルスカベット 溶融顆粒化された調合物及びこの調合物から製造された、放出が調節された投薬形
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
AU2002338855B2 (en) 2007-08-16
HRP20030950A2 (en) 2005-08-31
AR033896A1 (es) 2004-01-07
SK15542003A3 (sk) 2004-05-04
NZ547636A (en) 2008-03-28
IL158733A0 (en) 2004-05-12
KR20030097890A (ko) 2003-12-31
UA80092C2 (en) 2007-08-27
JP2004530695A (ja) 2004-10-07
IS7020A (is) 2003-11-10
CZ20033269A3 (en) 2004-03-17
EA009731B1 (ru) 2008-02-28
EA200301282A1 (ru) 2004-04-29
BR0209834A (pt) 2004-06-15
EP1389091A1 (en) 2004-02-18
WO2002094225A1 (en) 2002-11-28
YU92103A (sh) 2006-05-25
MXPA03010596A (es) 2004-03-09
CA2447603A1 (en) 2002-11-28
NO20035146L (no) 2003-11-19
HUP0400051A2 (hu) 2004-04-28
EA200700703A1 (ru) 2007-08-31
CN1511026A (zh) 2004-07-07
BG108441A (en) 2005-02-28
NO20035146D0 (no) 2003-11-19
PL366541A1 (en) 2005-02-07
ZA200308594B (en) 2004-11-04
US20040157876A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
EP1578910A4 (en) NITRILASES
GB2376583B (en) Time alignment of signals
IL157426A0 (en) Peg-conjugates of hgf-nk4
EP1420651A4 (en) PRESERVATION OF AGRICULTURAL PRODUCTS
IL158733A0 (en) Granular preparations of gaboxadol
AU2002359694A8 (en) Compounds and methods
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB0126889D0 (en) Compounds and their uses
GB0125708D0 (en) Novel compounds and processes
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
AU2002358719A1 (en) Agaricoglycerides and analogs
EP1379240A4 (en) CONNECTIONS AND METHODS
GB0100151D0 (en) Methods of sputtering
IL157243A0 (en) Preparation of n-methylparoxetine and related intermediate compounds
TW493722U (en) Improved structure of lampwick
EP1435953A4 (en) ANTI-VESICANS COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE
HU0104370D0 (en) Honeyed schnaps of oerseg
AU2002359898A1 (en) Preparation of alpha-diimines
AU150489S (en) Set of chamfered logs
TW573751U (en) Structure capable of preventing jaming
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
GB0105097D0 (en) Treatment of technetium
GB0104615D0 (en) Treatment of technetium
AU2002335011A1 (en) Compounds and methods